MAXCYTE INC. - COMMON
3,3800
26-ноября-24 15:45:00
15 мин. задержка
Акции
-0,2300
-6,37%
Сегодняшний диапазон
3,3300 - 3,6100
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
12 апр 2022 15:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Reports Fourth Quarter and Full Year Financial Results
22 мар 2022 15:05:01 Источник Nasdaq GlobeNewswire
-
MaxCyte, Inc. Names Cenk Sumen Chief Scientific Officer
09 мар 2022 15:15:00 Источник Nasdaq GlobeNewswire
-
MaxCyte to Report Fourth Quarter and Full Year 2021 Financial Results on March 22, 2022
24 фев 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
14 фев 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 фев 2022 16:00:00 Источник Nasdaq GlobeNewswire
-
01 фев 2022 01:00:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Announces Strong Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue Results
24 янв 2022 01:30:00 Источник Nasdaq GlobeNewswire
-
MaxCyte to Participate in Upcoming Investor Conferences
12 ноя 2021 07:00:01 Источник Nasdaq GlobeNewswire
-
MaxCyte Reports Third Quarter Financial Results
10 ноя 2021 15:00:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Board Member Richard Douglas, PhD, Appointed Chairman of the Board
03 ноя 2021 08:00:02 Источник Nasdaq GlobeNewswire
-
29 окт 2021 11:40:00 Источник Nasdaq GlobeNewswire
-
28 окт 2021 09:00:00 Источник Nasdaq GlobeNewswire
-
MaxCyte to Report Third Quarter 2021 Financial Results on November 10, 2021
25 окт 2021 15:30:00 Источник Nasdaq GlobeNewswire
-
MaxCyte Set to Join Russell 2000® Index
17 сен 2021 07:35:00 Источник Nasdaq GlobeNewswire
-
13 сен 2021 15:05:00 Источник Nasdaq GlobeNewswire
-
MaxCyte to Report Second Quarter 2021 Financial Results on September 13, 2021
02 сен 2021 07:05:00 Источник Nasdaq GlobeNewswire